The prevalence of five types of hyperlipoproteinemia identified by Fredrickson, Levy 
A CORRELATION between elevated serum cholesterol and triglyceride levels and the prevalence and incidence of ischemic heart disease'-5 has been established. It has been emphasized, however, that since these two lipids along with phospholipids are transported in blood as integral parts of lipoproteins, it is most rational to relate disordered lipid metabolism to coronary atherosclerosis in terms of serum lipoprotein levels. 5 This approach was advocated with little acceptance almost 20 years ago6 and has been validated only recently since it was demonstrated by Fredrickson, Levy, and Lees7-11 that a variety of hyperlipoproteinemic states exists, each with its characteristic clinical and biochemical features and each requiring a particular form of therapy. Although the association of one of these disorders, namely type II hyperlipoproteinemia (familial hypercholesterol-emia) with premature coronary atherosclerosis has long been recognized in clinical practice and more recently from epidemiologic studies,12 the relationship of other types, i.e. I, III, IV, and V, to this disease is less well defined since there have been no prospective studies of populations in which these hyperlipoproteinemias have been identified. While early prospective studies from the Albany Cardiovascular Health Center which reported on the significance of elevated triglyceride levels4 did not include lipoprotein typing, subsequent studies'3 revealed that elevated triglyceride levels in these subjects represented elevated very low-density lipoproteins. It would appear likely, therefore, that the increased prevalence and incidence of ischemic heart disease in these subjects with elevated triglyceride levels is synonymous with a relationship between this disease and type IV hyperlipoproteinemia. Recent coronary angiographic studies tend to support this relationship. '4-17 Since it appears likely that at least two types of hyperlipoproteinemia are related to atherogenesis, it is important that this relationship be defined more precisely than hitherto and supplemented with information on other types of hyperlipoproteinemia. The potential magnitude of the problem can be assessed by measuring the Circulation. Volume Figure 4 Type IV hyperlipoproteinemia. Prevalence by age and sex.
in males aged 35-44 years with a rate of 374/1000. In the 55-64-year age range, the rate in women was 194/1000, but with only 36 subjects in this group this rate cannot be considered reliable. In the age range 25-54 years this disorder was significantly more prevalent in males than females (P<0.05). The small number of subjects at the ends of the age spectrum precluded statistical analysis. Plasma lipid levels in the subjects with type IV hyperlipoproteinemia are summarized in table 2. The mean plasma triglyceride level in this disorder was 246 + 97 mg% compared with a value of 84 ±41 mg% in normal subjects. HDL cholesterol levels were significantly lower than normal in males (P < 0.05) and in female subjects (P < 0.01) with type IV hyperlipoproteinemia, 36 ± 20 vs 40 + 19 and 38 ± 21 vs 47 + 19, respectively. Plasma total cholesterol level was significantly elevated (P <0.01) in type IV hyperlipoproteinemia with a value of 226 + 35 mg% as compared with a value of 194 + 33 mg% in normal subjects. Significant sex differences in lipid levels were not encountered in subjects with type IV hyperlipoproteinemia.
Type II hyperlipoproteinemia was more prevalent in females than males-104/ 1000 vs 88/1000, but this difference was not statistically significant. Prevalence rates are summarized in figure 5 and plasma lipid levels in subjects with type II hyperlipoproteinemia are summarized in table 3. Mean plasma LDL cholesterol was 215 + 27 mg% in subjects with type II hyperlipoproteinemia compared with 134 ± 30 mg% in normal subjects. In view of the much higher prevalence of the type IV disorder in males, one cannot help but speculate on the possible role that the disorder may play in the greater susceptibility of the male sex to coronary atherosclerosis. Recent studies utilizing coronary angiography have emphasized the high prevalence of this disorder in those with diseased vessels.14-17 Since subjects in these studies have, however, been predominantly male and have included relatively few subjects with healthy vessels, a high prevalence of the type IV disorder in this particular group cannot be considered conclusive evidence of its atherogenicity. Since this study and that of Wood et al. reveal that the disorder is so prevalent in the male population at large, more conclusive evidence of its atherogenicity must await the demonstration of a low prevalence of the type IV disorder in males with healthy vessels compared to age-matched subjects with diseased vessels and the possible demonstration that the prevalence of the type IV disorder in women with diseased vessels is significantly higher than that encountered in the general female population.
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